Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment

NCT02601859 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT02601859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment
Lead sponsor
University of Dundee
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2016
Completion date
June 30, 2017
Enrollment
11 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment